Implantable Defibrillators Market byType (Single Chambered, Double Chambered, Biventricular Chambered), Procedure Type (Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Cardiac Resynchronization Therapy Defibrillator (CRT-D)), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Abstract
"Market Definition:

The global implantable defibrillator market was valued at USD 7.35 billion in 2019 and is predicted to reach USD 11.44 billion by 2030 with a CAGR of 4.1% from 2020-2030.

Implantable defibrillator is a tiny battery powered device implanted in the chest of a patient in order to monitor his heart conditions. The device is connected to the heart of the patient through a thin wire so that it can continuously monitor the patient’s heart rate and send electrical impulses to restore the normal heart rhythm in case any abnormality is detected. It is very useful in treating sudden cardiac arrest caused due to ventricular fibrillation, cardiac arrhythmias, especially in cases of pulseless ventricular tachycardia.

Market Dynamics and Trends

According to Centers of Disease Control (CDC), around 735,000 Americans suffer a heart attack every year, out of these 525,000 have the attack for the first time, while 210,000 have second incidences of the heart attack. In the U.K., stroke occurs every 100,000 times a year, and there were an estimated 1.2 Mn stroke survivors in the U.K. in 2018, according to Stroke association of U.K. Factors such as increased incidence of sudden cardiac arrest (SCA), introduction of technologically advanced implantable defibrillators and the rising geriatric population around the world are majorly driving the implantable defibrillators market. However, limited insurance coverage, high cost and lack of awareness towards the advantage of using implantable defibrillators are hampering the growth of the implantable defibrillators market.

Market Segmentations and Scope of the Study:

The implantable defibrillators market is segmented on the basis of product type and geography. On the basis of product type, the market is segmented into transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillators (S-ICDs), and cardiac resynchronization therapy defibrillator (CRT-D). Also, the geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and ROW.

Geographical Analysis

North America denotes higher adoption of the implantable defibrillators and is anticipated to hold the highest implantable defibrillators market share during the forecast period. This is attributable to the factors including the rapid developments of its healthcare infrastructure, high R&D investments, high consumer awareness, increasing incidences of cardiovascular diseases, and increased demand for implantable defibrillators.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to improvement in the healthcare facilities, and increasing cardiac disorders, arrhythmias, & sudden cardiac arrest diseases due to the changing lifestyle and rising levels of pollution in countries like China, India and others.

Competitive Landscape

Comprehensive competitive analysis and profiles of the major market players such as LivaNova PLC Company, Imricor Medical Systems, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., Boston Scientific Corporation, MicroPort Scientific Corporation, St. Jude Medical, Inc., Biotronik Se & Co.KG, Sorin Group, and others are provided in the implantable defibrillators market report.

KEY MARKET SEGMENTS:
• Global Implantable Defibrillators Market – By Product Type
- Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
- Cardiac Resynchronization Therapy Defibrillator (CRT-D)

• Global Implantable Defibrillators Market –By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- RoW
- Brazil
- Argentina
- Egypt
- Israel
- South Africa
- Remaining Countries"

Content
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD/VOLUME
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
5.2.1 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION
5.2.1.1 North America Subcutaneous Implantable Cardioverter Defibrillators Market, By Country
5.2.1.2 Europe Subcutaneous Implantable Cardioverter Defibrillators Market, By Country
5.2.1.3 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillators Market, By Country
5.2.1.4 Rest of World Subcutaneous Implantable Cardioverter Defibrillators Market, By Country
5.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
5.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR MARKET, BY REGION
5.3.1.1 North America Transvenous Implantable Cardioverter-Defibrillator Market, By Country
5.3.1.2 Europe Transvenous Implantable Cardioverter-Defibrillator Market, By Country
5.3.1.3 Asia-Pacific Transvenous Implantable Cardioverter-Defibrillator Market, By Country
5.3.1.4 Rest of World Transvenous Implantable Cardioverter-Defibrillator Market, By Country
5.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
5.4.1 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR MARKET, BY REGION
5.4.1.1 North America Cardiac Resynchronization Therapy Defibrillator Market, By Country
5.4.1.2 Europe Cardiac Resynchronization Therapy Defibrillator Market, By Country
5.4.1.3 Asia-Pacific Cardiac Resynchronization Therapy Defibrillator Market, By Country
5.4.1.4 Rest of World Cardiac Resynchronization Therapy Defibrillator Market, By Country
6. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1 NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
6.2.2 NORTH AMERICA IMPLANTABLE DEFIBRILLATORS, MARKET BY COUNTRY
6.2.2.1 U.S.
6.2.2.1.1 U.S. Implantable Defibrillators Market, By Product Type
6.2.2.2 Canada
6.2.2.2.1 Canada Implantable Defibrillators Market, By Product Type
6.2.2.3 Mexico
6.2.2.3.1 Mexico Implantable Defibrillators Market, By Product Type
6.3. EUROPE
6.3.1 EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
6.3.2 EUROPE IMPLANTABLE DEFIBRILLATORS, MARKET BY COUNTRY
6.3.2.1 Germany
6.3.2.1.1 Germany Implantable Defibrillators Market, By Product Type
6.3.2.2 UK
6.3.2.2.1 UK Implantable Defibrillators Market, By Product Type
6.3.2.3 France
6.3.2.3.1 France Implantable Defibrillators Market, By Product Type
6.3.2.4 Italy
6.3.2.4.1 Italy Implantable Defibrillators Market, By Product Type
6.3.2.5 Spain
6.3.2.5.1 Spain Implantable Defibrillators Market, By Product Type
6.3.2.6 Rest of Europe
6.3.2.6.1 Rest of Europe Implantable Defibrillators Market, By Product Type
6.4. ASIA-PACIFIC
6.4.1 ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
6.4.2 ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS, MARKET BY COUNTRY
6.4.2.1 China
6.4.2.1.1 China Implantable Defibrillators Market, By Product Type
6.4.2.2 India
6.4.2.2.1 India Implantable Defibrillators Market, By Product Type
6.4.2.3 Japan
6.4.2.3.1 Japan Implantable Defibrillators Market, By Product Type
6.4.2.4 Australia
6.4.2.4.1 Australia Implantable Defibrillators Market, By Product Type
6.4.2.5 Rest of Asia-Pacific
6.4.2.5.1 Rest of Asia-Pacific Implantable Defibrillators Market, By Product Type
6.5. REST OF WORLD
6.5.1 REST OF WORLD IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
6.5.2 REST OF WORLD IMPLANTABLE DEFIBRILLATORS, MARKET BY COUNTRY
6.5.2.1 Brazil
6.5.2.1.1 Brazil Implantable Defibrillators Market, By Product Type
6.5.2.2 South Africa
6.5.2.2.1 South Africa Implantable Defibrillators Market, By Product Type
6.5.2.3 Argentina
6.5.2.3.1 Argentina Implantable Defibrillators Market, By Product Type
6.5.2.4 Egypt
6.5.2.4.1 Egypt Implantable Defibrillators Market, By Product Type
6.5.2.5 Israel
6.5.2.5.1 Israel Implantable Defibrillators Market, By Product Type
6.5.2.6 Remaining Countries
6.5.2.6.1 Remaining Countries Implantable Defibrillators Market, By Product Type
7. COMPANY PROFILES
7.1. BOSTON SCIENTIFIC CORPORATION
7.1.1 COMPANY OVERVIEW
7.1.2 COMPANY SNAPSHOT
7.1.3 OPERATING BUSINESS SEGMENTS
7.1.4 PRODUCT PORTFOLIO
7.1.5 BUSINESS PERFORMANCE
7.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.2. LIVANOVA PLC COMPANY
7.2.1 COMPANY OVERVIEW
7.2.2 COMPANY SNAPSHOT
7.2.3 OPERATING BUSINESS SEGMENTS
7.2.4 PRODUCT PORTFOLIO
7.2.5 BUSINESS PERFORMANCE
7.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.3. IMRICOR MEDICAL SYSTEMS
7.3.1 COMPANY OVERVIEW
7.3.2 COMPANY SNAPSHOT
7.3.3 OPERATING BUSINESS SEGMENTS
7.3.4 PRODUCT PORTFOLIO
7.3.5 BUSINESS PERFORMANCE
7.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.4. MICROPORT SCIENTIFIC CORPORATION
7.4.1 COMPANY OVERVIEW
7.4.2 COMPANY SNAPSHOT
7.4.3 OPERATING BUSINESS SEGMENTS
7.4.4 PRODUCT PORTFOLIO
7.4.5 BUSINESS PERFORMANCE
7.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.5. MAYO CLINIC US
7.5.1 COMPANY OVERVIEW
7.5.2 COMPANY SNAPSHOT
7.5.3 OPERATING BUSINESS SEGMENTS
7.5.4 PRODUCT PORTFOLIO
7.5.5 BUSINESS PERFORMANCE
7.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.6. MEDTRONIC PLC
7.6.1 COMPANY OVERVIEW
7.6.2 COMPANY SNAPSHOT
7.6.3 OPERATING BUSINESS SEGMENTS
7.6.4 PRODUCT PORTFOLIO
7.6.5 BUSINESS PERFORMANCE
7.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.7. MRI INTERVENTIONS, INC.
7.7.1 COMPANY OVERVIEW
7.7.2 COMPANY SNAPSHOT
7.7.3 OPERATING BUSINESS SEGMENTS
7.7.4 PRODUCT PORTFOLIO
7.7.5 BUSINESS PERFORMANCE
7.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.8. ST. JUDE MEDICAL, INC.
7.8.1 COMPANY OVERVIEW
7.8.2 COMPANY SNAPSHOT
7.8.3 OPERATING BUSINESS SEGMENTS
7.8.4 PRODUCT PORTFOLIO
7.8.5 BUSINESS PERFORMANCE
7.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.9. BIOTRONIK SE & CO.KG
7.9.1 COMPANY OVERVIEW
7.9.2 COMPANY SNAPSHOT
7.9.3 OPERATING BUSINESS SEGMENTS
7.9.4 PRODUCT PORTFOLIO
7.9.5 BUSINESS PERFORMANCE
7.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.10. SORIN GROUP
7.10.1 COMPANY OVERVIEW
7.10.2 COMPANY SNAPSHOT
7.10.3 OPERATING BUSINESS SEGMENTS
7.10.4 PRODUCT PORTFOLIO
7.10.5 BUSINESS PERFORMANCE
7.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT